{"id":36,"date":"2020-08-18T14:46:51","date_gmt":"2020-08-18T18:46:51","guid":{"rendered":"https:\/\/scholarrock301.wpengine.com\/?page_id=36"},"modified":"2024-11-18T11:49:09","modified_gmt":"2024-11-18T16:49:09","slug":"clinical-trials","status":"publish","type":"page","link":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/","title":{"rendered":"Clinical Trials"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"36\" class=\"elementor elementor-36\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-57ff511 top-row narrow-row elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"57ff511\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b8f5531\" data-id=\"b8f5531\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-b7cee2b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b7cee2b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-86e02d1\" data-id=\"86e02d1\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7cce940 elementor-widget elementor-widget-text-editor\" data-id=\"7cce940\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>We are unflinching in the face of serious disease. We embrace innovation fully in our efforts to develop and investigate novel medicines and science.<\/p><p><a class=\"button\" href=\"\/our-pipeline\/\">Learn More About Our Indications <\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-fed51b9\" data-id=\"fed51b9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-1056c8d elementor-section-content-middle topaz-row elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1056c8d\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-a5224b1\" data-id=\"a5224b1\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6ef5504 elementor-widget elementor-widget-image\" data-id=\"6ef5504\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"328\" height=\"328\" src=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg\" class=\"attachment-full size-full wp-image-710\" alt=\"Topaz logo\" srcset=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg 328w, https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz-300x300.jpg 300w, https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz-150x150.jpg 150w, https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz-75x75.jpg 75w\" sizes=\"(max-width: 328px) 100vw, 328px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-2e5d7d3\" data-id=\"2e5d7d3\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-667b39d elementor-widget elementor-widget-text-editor\" data-id=\"667b39d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Spinal Muscular Atrophy<\/h2><p><strong>TOPAZ<\/strong><\/p><p>The TOPAZ Phase 2 proof of concept trial evaluated the safety and efficacy of apitegromab (SRK-015) in patients with Type 2 and Type 3 SMA.<\/p><p>The trial enrolled 58 patients between the ages of 2 and 21 in the U.S. and Europe across three distinct cohorts. All patients received apitegromab once every four weeks either as a monotherapy or in conjunction with an approved SMN upregulator treatment over a 12-month treatment period. The primary efficacy endpoints measure motor function through clinically meaningful outcome measures validated in SMA, such as the Hammersmith Functional Motor Scale Expanded (HFMSE) in non-ambulatory SMA and the Revised Hammersmith Scale (RHS) in ambulatory SMA.<\/p><p>A pre-planned interim analysis was conducted following a six-month treatment period, and positive proof-of-concept data were announced in October 2020. Top-line results for the full 12-month treatment period were announced in April 2021.<\/p><p><a class=\"external-link\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03921528\">Learn More About TOPAZ at clinicaltrials.gov<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-ab6ac07 elementor-section-content-middle dragon-row elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ab6ac07\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-1e36d42\" data-id=\"1e36d42\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b388319 elementor-widget elementor-widget-text-editor\" data-id=\"b388319\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><strong>SAPPHIRE<\/strong><\/p><p>SAPPHIRE was a randomized, double-blind, placebo-controlled Phase 3 clinical trial that evaluated the safety and efficacy of apitegromab in nonambulatory patients with Types 2 and 3 SMA who are receiving current standard of care (either nusinersen or risdiplam). SAPPHIRE enrolled 156 patients aged 2-12 years old in the main efficacy population. These patients were randomized 1:1:1 to receive for 12 months either apitegromab 10 mg\/kg, apitegromab 20 mg\/kg, or placebo by intravenous (IV) infusion every 4 weeks. An exploratory population that enrolled 32 patients aged 13-21 years old was also evaluated. These patients were randomized 2:1 to receive either apitegromab 20 mg\/kg or placebo.<\/p><p><a class=\"external-link\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT05156320\">Learn more about SAPPHIRE at clinicaltrials.gov<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-4d7f32c\" data-id=\"4d7f32c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-30ece10 dragon-logo elementor-widget elementor-widget-image\" data-id=\"30ece10\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"164\" height=\"164\" src=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2021\/12\/sapphire.svg\" class=\"attachment-full size-full wp-image-1034\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-f8a86b0 elementor-section-content-middle dragon-row elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f8a86b0\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-1a305fe\" data-id=\"1a305fe\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e2c6bfc dragon-logo elementor-widget elementor-widget-image\" data-id=\"e2c6bfc\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/10\/dragon.svg\" class=\"attachment-full size-full wp-image-884\" alt=\"Dragon Logo\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-2262083\" data-id=\"2262083\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2271558 elementor-widget elementor-widget-text-editor\" data-id=\"2271558\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Immuno-Oncology<\/h2><p><strong>DRAGON<\/strong><\/p><p>The DRAGON trial is investigating SRK-181, a selective inhibitor of TGF\u03b21 activation, in patients with locally advanced or metastatic solid tumors that have shown primary resistance to checkpoint inhibitor therapies. Part A was designed to assess safety and tolerability of SRK-181.\u00a0 With some results of Part A available, Part B dose expansion portion of the trial is now underway to evaluate SRK-181 in combination with an approved anti-PD-(L)1 therapy across multiple solid tumor cohorts to test proof of consent.<\/p><p><a class=\"external-link\" href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04291079\">Learn more about DRAGON at clinicaltrials.gov<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-4c4cb34 elementor-widget elementor-widget-text-editor\" data-id=\"4c4cb34\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<h2>Expanded Access Policy<\/h2><p><a class=\"text-button\" href=\"\/expanded-access-policy\/\">View Our Expanded Access Policy<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-95565b1 seeking-info-row border-top elementor-widget elementor-widget-text-editor\" data-id=\"95565b1\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">Patients seeking more information on potential clinical trials should contact their physician.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>We are unflinching in the face of serious disease. We embrace innovation fully in our efforts to develop and investigate novel medicines and science. Learn More About Our Indications Spinal Muscular Atrophy TOPAZ The TOPAZ Phase 2 proof of concept trial evaluated the safety and efficacy of apitegromab (SRK-015) in patients with Type 2 and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":26,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"class_list":{"0":"post-36","1":"page","2":"type-page","3":"status-publish","5":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Clinical Trials at Scholar Rock<\/title>\n<meta name=\"description\" content=\"We are unwavering in the face of serious disease and fully embrace non traditional methods to find novel medicines. Learn more about our clinical trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Trials at Scholar Rock\" \/>\n<meta property=\"og:description\" content=\"We are unwavering in the face of serious disease and fully embrace non traditional methods to find novel medicines. Learn more about our clinical trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Scholar Rock\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T16:49:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"328\" \/>\n\t<meta property=\"og:image:height\" content=\"328\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ScholarRock\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/\",\"url\":\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/\",\"name\":\"Clinical Trials at Scholar Rock\",\"isPartOf\":{\"@id\":\"https:\/\/scholarrock.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg\",\"datePublished\":\"2020-08-18T18:46:51+00:00\",\"dateModified\":\"2024-11-18T16:49:09+00:00\",\"description\":\"We are unwavering in the face of serious disease and fully embrace non traditional methods to find novel medicines. Learn more about our clinical trials.\",\"breadcrumb\":{\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#primaryimage\",\"url\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg\",\"contentUrl\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg\",\"width\":328,\"height\":328,\"caption\":\"Topaz logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/scholarrock.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Pipeline\",\"item\":\"https:\/\/scholarrock.com\/our-pipeline\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/scholarrock.com\/#website\",\"url\":\"https:\/\/scholarrock.com\/\",\"name\":\"Scholar Rock\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/scholarrock.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/scholarrock.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/scholarrock.com\/#organization\",\"name\":\"Scholar Rock\",\"url\":\"https:\/\/scholarrock.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/scholarrock.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/08\/Logo.svg\",\"contentUrl\":\"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/08\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Scholar Rock\"},\"image\":{\"@id\":\"https:\/\/scholarrock.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ScholarRock\",\"https:\/\/www.linkedin.com\/company\/scholar-rock\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Trials at Scholar Rock","description":"We are unwavering in the face of serious disease and fully embrace non traditional methods to find novel medicines. Learn more about our clinical trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Trials at Scholar Rock","og_description":"We are unwavering in the face of serious disease and fully embrace non traditional methods to find novel medicines. Learn more about our clinical trials.","og_url":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/","og_site_name":"Scholar Rock","article_modified_time":"2024-11-18T16:49:09+00:00","og_image":[{"width":328,"height":328,"url":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@ScholarRock","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/","url":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/","name":"Clinical Trials at Scholar Rock","isPartOf":{"@id":"https:\/\/scholarrock.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg","datePublished":"2020-08-18T18:46:51+00:00","dateModified":"2024-11-18T16:49:09+00:00","description":"We are unwavering in the face of serious disease and fully embrace non traditional methods to find novel medicines. Learn more about our clinical trials.","breadcrumb":{"@id":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#primaryimage","url":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg","contentUrl":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/09\/topaz.jpg","width":328,"height":328,"caption":"Topaz logo"},{"@type":"BreadcrumbList","@id":"https:\/\/scholarrock.com\/our-pipeline\/clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/scholarrock.com\/"},{"@type":"ListItem","position":2,"name":"Our Pipeline","item":"https:\/\/scholarrock.com\/our-pipeline\/"},{"@type":"ListItem","position":3,"name":"Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/scholarrock.com\/#website","url":"https:\/\/scholarrock.com\/","name":"Scholar Rock","description":"","publisher":{"@id":"https:\/\/scholarrock.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/scholarrock.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/scholarrock.com\/#organization","name":"Scholar Rock","url":"https:\/\/scholarrock.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/scholarrock.com\/#\/schema\/logo\/image\/","url":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/08\/Logo.svg","contentUrl":"https:\/\/scholarrock.com\/wp-content\/uploads\/2020\/08\/Logo.svg","width":1,"height":1,"caption":"Scholar Rock"},"image":{"@id":"https:\/\/scholarrock.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ScholarRock","https:\/\/www.linkedin.com\/company\/scholar-rock\/"]}]}},"_links":{"self":[{"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/pages\/36","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/comments?post=36"}],"version-history":[{"count":0,"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/pages\/36\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/pages\/26"}],"wp:attachment":[{"href":"https:\/\/scholarrock.com\/wp-json\/wp\/v2\/media?parent=36"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}